| Page 1996 | Kisaco Research
 

Dr Maria Kyrgiou

Clinical Senior Lecturer
Imperial College London

Dr Maria Kyrgiou is a Clinical Senior Lecturer at Imperial College London and Consultant Gynaecologist and Gynaecologic Oncologist at the West London Gynaecological Cancer Centre, Imperial Healthcare NHS Trust.

Dr Maria Kyrgiou

Clinical Senior Lecturer
Imperial College London

Dr Maria Kyrgiou

Clinical Senior Lecturer
Imperial College London

Dr Maria Kyrgiou is a Clinical Senior Lecturer at Imperial College London and Consultant Gynaecologist and Gynaecologic Oncologist at the West London Gynaecological Cancer Centre, Imperial Healthcare NHS Trust.

The primary focus of her research is traslational research in gynaecological cancers, in particular cervical and endometrial cancer. She has led research into the impact of treatment for cervical pre-invasive and early invasive cervical disease on reproductive outcomes and the clinical use of HPV biomarkers in personalising the management of women with abnormal findings at screening. She has an interest in the role of obesity and metabolic disorders in endometrial tumorigenesis.

 

Katri Korpela

Professor
Department of Bacteriology and Immunology, University of Helsinki

Katri Korpela

Professor
Department of Bacteriology and Immunology, University of Helsinki

Katri Korpela

Professor
Department of Bacteriology and Immunology, University of Helsinki
 

Aletta Kraneveld

Professor of Pharmacology
Utrecht University

In 2016 Aletta Kraneveld (MSc Pharmacy & pharmacologist) was appointed as full professor Interdisciplinary Translational Pharmacology at the Faculty of Science and the Faculty of Veterinary Medicine of the Utrecht University. She has published >120 papers (H-index: 42). Besides science, she is/has been an active member of several boards of (inter)national scientific and societal organizations (Dutch Society of Pharmacology, EPHAR, IUPHAR, Netherlands Federation of Innovative Drug research; Diversity committee UU; Food Lives-NL).

Aletta Kraneveld

Professor of Pharmacology
Utrecht University

Aletta Kraneveld

Professor of Pharmacology
Utrecht University

In 2016 Aletta Kraneveld (MSc Pharmacy & pharmacologist) was appointed as full professor Interdisciplinary Translational Pharmacology at the Faculty of Science and the Faculty of Veterinary Medicine of the Utrecht University. She has published >120 papers (H-index: 42). Besides science, she is/has been an active member of several boards of (inter)national scientific and societal organizations (Dutch Society of Pharmacology, EPHAR, IUPHAR, Netherlands Federation of Innovative Drug research; Diversity committee UU; Food Lives-NL).

Kraneveld’s current research interests involve targeting the interaction between innate and adaptive immunity as well as host-microbiome interactions in chronic (inflammatory) diseases with pharmaceutical as well as nutritional interventions. The Kraneveld group is focusing research to in depth study the role of the gut-immune-brain-axis in neurodevelopmental and neurodegenerative disorders. Results will further enhance the knowledge of the interaction of microbiome with the immune and nervous systems in chronic conditions in the gut and CNS. Aletta Kraneveld has set up a program that is a (inter)national neuro-immune platform where academia, patient organisations and industry meet for research on the gut-immune-brain axis as target for medicine and medical food concepts. 

 

Ian MacLeod

Senior Associate
Carpmaels & Ransford

Ian is a UK and European Patent Attorney and his practice covers a wide range of biotechnological subject-matter, with particular focus on live biotherapeutics, biomarker diagnostics, vaccines, antibody therapeutics, and antisense nucleotides.

 

Ian MacLeod

Senior Associate
Carpmaels & Ransford

Ian MacLeod

Senior Associate
Carpmaels & Ransford

Ian is a UK and European Patent Attorney and his practice covers a wide range of biotechnological subject-matter, with particular focus on live biotherapeutics, biomarker diagnostics, vaccines, antibody therapeutics, and antisense nucleotides.

 

Ian enjoys working for a range of clients, from multinational pharmaceutical firms to a number of university spin-outs and start-ups, many of which he has helped for years as their businesses develop. As such, Ian has extensive experience drafting and filing patent applications to build up portfolios and then coordinating the prosecution of applications around the world. Ian also has a substantial opposition practice and represents his clients defending and opposing key patents, in particular at the European Patent Office.

 

Simon Blackmore

Professor
Harper Adams University

Simon Blackmore is a key figure in the development of Precision Farming and agricultural robotics, with a world-wide reputation. Simon is currently Professor and Head of Robotics and Automation, Agri-Epi Centre at Harper Adams University, Director of the National Centre for Precision Farming and managed the European FutureFarm project.

Simon has extensive experience of multidisciplinary collaboration across universities, commercial partnerships and research projects including autonomous tractors, laser weeding, robotic phenotyping and robotic harvesting.

Simon Blackmore

Professor
Harper Adams University

Simon Blackmore

Professor
Harper Adams University

Simon Blackmore is a key figure in the development of Precision Farming and agricultural robotics, with a world-wide reputation. Simon is currently Professor and Head of Robotics and Automation, Agri-Epi Centre at Harper Adams University, Director of the National Centre for Precision Farming and managed the European FutureFarm project.

Simon has extensive experience of multidisciplinary collaboration across universities, commercial partnerships and research projects including autonomous tractors, laser weeding, robotic phenotyping and robotic harvesting.

Simon holds seven Chairs around the world and gives many national and international keynote presentations. Simon leads the research in the UK on agricultural robotics.

Simon personal research focuses on improving Precision Farming by developing more intelligent machines and processes, and making crop production more efficient and sustainable.

 

Dr. Huub Schepers

Wageningen University

Dr. Huub Schepers

Wageningen University

Dr. Huub Schepers

Wageningen University
 

Dr. Fideline Tchuenbou-Magaia

University of Wolverhampton

Dr Fideline Tchuenbou-Magaia is a senior lecturer at the University of Wolverhampton, UK. She has more than 10 year experience in formulation engineering with focus on encapsulation and controlled release of molecules. Dr Tchuenbou-Magaia has developed controlled release formulations with application primarily in food and nutraceuticals, oral healthcare and cosmetics, agrochemical, energy storage and carbon capture.

Dr. Fideline Tchuenbou-Magaia

University of Wolverhampton

Dr. Fideline Tchuenbou-Magaia

University of Wolverhampton

Dr Fideline Tchuenbou-Magaia is a senior lecturer at the University of Wolverhampton, UK. She has more than 10 year experience in formulation engineering with focus on encapsulation and controlled release of molecules. Dr Tchuenbou-Magaia has developed controlled release formulations with application primarily in food and nutraceuticals, oral healthcare and cosmetics, agrochemical, energy storage and carbon capture. Further information about Dr Tchuenbou-Magaia can be found on the University of Wolverhampton website, https://www.wlv.ac.uk/about-us/our-schools-and-institutes/faculty-of-science-and-engineering/all-faculty-staff/school-of-engineering-staff/dr-fideline-laure-tchuenbou-magaia/

 

Ketan Mehta

CEO
Ecosense, India

Ketan Mehta

CEO
Ecosense, India

Ketan Mehta

CEO
Ecosense, India
 

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany

Dr. Anant Patel

Bielefeld University of Applied Sciences Germany
 
Health, Wellness & Money
21 Nov 2017
London, UK
Health, Wellness & Money is THE destination for the hottest early to mid-stage OTC health and wellness companies and healthtech innovators to connect with Strategic and Financial Buyers looking to build even more enterprise value with their next acquisition or investment.Every attendee, via the MEETING MOJO platform, will be able to schedule 12+ One-to-One private meetings to ensure the right connections are made.Why Consumer Health & Wellness? $3.4 TRILLION GLOBAL WELLNESS MARKET IS NOW THREE TIMES LARGER THAN WORLDWIDE PHARMACEUTICAL INDUSTRY. Global Wellness Institute StudyWellness sectors seeing the most significant growth since 2010 are:Healthy eating, nutrition and weight loss (108 percent increase to $276.5 billion)Preventative and personalized health (78 percent increase to $243 billion)Complementary and alternative medicine (65 percent increase to $113 billion)